The federal contract IDV award SPE2DV17D2063 is a single-award Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. This $4,999,999 contract, awarded by the Defense Logistics Agency (DLA), provides a flexible procurement mechanism for the U.S. government to rapidly order a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515. The contract enables Cardinal Health 200, LLC to fulfill delivery orders for critical medical supplies, including surgical dressings, drugs, biologicals, medical consumables, and specialized medical equipment, in support of military treatment facilities and other Department of Defense healthcare providers. This IDC, effective through June 2027, underscores Cardinal Health's strategic importance as a prime vendor in the federal healthcare supply chain, particularly for defense-related medical and pharmaceutical needs.
The parent company, Cardinal Health, Inc., is a major global healthcare services and products company that has held numerous federal contract awards, primarily with the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. These contracts cover a wide range of pharmaceutical and medical product distribution services, including the supply of prescription medications, over-the-counter drugs, vaccines, radiopharmaceuticals, and other essential medical consumables. Cardinal Health's involvement in federal grant programs appears to be more limited, with one notable exception being its participation in the distribution of naloxone under a COVID-19 supplemental grant awarded to the Tennessee Department of Mental Health & Substance Abuse Services.
Generated 7/2/25, 10:56 PM